Retinal pigment epithelium transplantation: concepts, challenges, and future prospects
- PMID: 26043704
- PMCID: PMC4541358
- DOI: 10.1038/eye.2015.89
Retinal pigment epithelium transplantation: concepts, challenges, and future prospects
Abstract
The retinal pigment epithelium (RPE) is a single layer of cells that supports the light-sensitive photoreceptor cells that are essential for retinal function. Age-related macular degeneration (AMD) is a leading cause of visual impairment, and the primary pathogenic mechanism is thought to arise in the RPE layer. RPE cell structure and function are well understood, the cells are readily sustainable in laboratory culture and, unlike other cell types within the retina, RPE cells do not require synaptic connections to perform their role. These factors, together with the relative ease of outer retinal imaging, make RPE cells an attractive target for cell transplantation compared with other cell types in the retina or central nervous system. Seminal experiments in rats with an inherited RPE dystrophy have demonstrated that RPE transplantation can prevent photoreceptor loss and maintain visual function. This review provides an update on the progress made so far on RPE transplantation in human eyes, outlines potential sources of donor cells, and describes the technical and surgical challenges faced by the transplanting surgeon. Recent advances in the understanding of pluripotent stem cells, combined with novel surgical instrumentation, hold considerable promise, and support the concept of RPE transplantation as a regenerative strategy in AMD.
Figures
Similar articles
-
Stem cell based therapies for age-related macular degeneration: The promises and the challenges.Prog Retin Eye Res. 2015 Sep;48:1-39. doi: 10.1016/j.preteyeres.2015.06.004. Epub 2015 Jun 23. Prog Retin Eye Res. 2015. PMID: 26113213 Review.
-
Advancing a Stem Cell Therapy for Age-Related Macular Degeneration.Curr Stem Cell Res Ther. 2020;15(2):89-97. doi: 10.2174/1574888X15666191218094020. Curr Stem Cell Res Ther. 2020. PMID: 31854278
-
Human retinal pigment epithelium (RPE) transplantation: outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomised clinical study.Br J Ophthalmol. 2011 Mar;95(3):370-5. doi: 10.1136/bjo.2009.176305. Epub 2010 Jul 7. Br J Ophthalmol. 2011. PMID: 20610478 Clinical Trial.
-
Sources of retinal pigment epithelium (RPE) for replacement therapy.Br J Ophthalmol. 2011 Apr;95(4):445-9. doi: 10.1136/bjo.2009.171918. Epub 2010 Jul 3. Br J Ophthalmol. 2011. PMID: 20601659 Review.
-
Stem cell therapies for age-related macular degeneration: the past, present, and future.Clin Interv Aging. 2015 Jan 14;10:255-64. doi: 10.2147/CIA.S73705. eCollection 2015. Clin Interv Aging. 2015. PMID: 25609937 Free PMC article. Review.
Cited by
-
Methods for culturing retinal pigment epithelial cells: a review of current protocols and future recommendations.J Tissue Eng. 2016 Jul 12;7:2041731416650838. doi: 10.1177/2041731416650838. eCollection 2016 Jan-Dec. J Tissue Eng. 2016. PMID: 27493715 Free PMC article. Review.
-
Stem cell sources and characterization in the development of cell-based products for treating retinal disease: An NEI Town Hall report.Stem Cell Res Ther. 2023 Mar 29;14(1):53. doi: 10.1186/s13287-023-03282-y. Stem Cell Res Ther. 2023. PMID: 36978104 Free PMC article.
-
Multiple Independent Oscillatory Networks in the Degenerating Retina.Front Cell Neurosci. 2015 Nov 9;9:444. doi: 10.3389/fncel.2015.00444. eCollection 2015. Front Cell Neurosci. 2015. PMID: 26617491 Free PMC article. Review.
-
The effects of platelet gel on cultured human retinal pigment epithelial (hRPE) cells.Bosn J Basic Med Sci. 2017 Nov 20;17(4):315-322. doi: 10.17305/bjbms.2017.2103. Bosn J Basic Med Sci. 2017. PMID: 28632489 Free PMC article.
-
The New Era of Therapeutic Strategies for the Treatment of Retinitis Pigmentosa: A Narrative Review of Pathomolecular Mechanisms for the Development of Cell-Based Therapies.Biomedicines. 2023 Sep 28;11(10):2656. doi: 10.3390/biomedicines11102656. Biomedicines. 2023. PMID: 37893030 Free PMC article. Review.
References
-
- Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48 (3:257–293. - PubMed
-
- Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004;122 (4:598–614. - PubMed
-
- Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Eng J Med. 2006;355 (14:1419–1431. - PubMed
-
- Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology. 2009;116 (1:57–65 e55. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical